| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | TOKAI PHARMACEUTICALS INC COM | 62,007 | 541,000 | 0.36% | ||
| 52 | Sierra Oncology, Inc. | 30,000 | 451,000 | 0.30% | ||
| 53 | Axovant Sciences LTD | 18,852 | 340,000 | 0.22% | ||
| 54 | Dipexium Pharmaceuticals Inc | 25,000 | 280,000 | 0.18% | ||
| 55 | INFINITY PHARMACEUTICALS INC | 30,000 | 236,000 | 0.16% | ||
| 56 | Carbylan Therapeutics Inc. | 17,500 | 63,000 | 0.04% | ||
| 57 | REPROS THERAPEUTICS INC | 98,000 | 33,000 | 0.02% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-16-004260, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
